PARVORUVAX, ενέσιμο διάλυμα για χοίρους
PARVORUVAX, ενέσιμο διάλυμα για χοίρους
Authorised
- Erysipelothrix rhusiopathiae, serotype 2, strain M2, Inactivated
- Porcine parvovirus, Inactivated
Product identification
Medicine name:
PARVORUVAX, ενέσιμο διάλυμα για χοίρους
Active substance:
- Erysipelothrix rhusiopathiae, serotype 2, strain M2, Inactivated
- Porcine parvovirus, Inactivated
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Erysipelothrix rhusiopathiae, serotype 2, strain M2, Inactivated25.00/international unit(s)1.00Dose
-
Porcine parvovirus, Inactivated64.00/haemagglutinating units1.00Dose
Pharmaceutical form:
-
Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AL01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete mixed application
Marketing authorisation holder:
- Ceva Hellas LLC
Marketing authorisation date:
Manufacturing sites for batch release:
- Merial
- Ceva-Phylaxia Zrt.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 36708/30-12-1991/K-0038801
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
